title: Reversible zidovudine-induced pure red cell aplasia.
authors.forename: P
authors.initials: P
authors.lastname: Blanche
authors.forename: B
authors.initials: B
authors.lastname: Silberman
authors.forename: L
authors.initials: L
authors.lastname: Barreto
authors.forename: B
authors.initials: B
authors.lastname: Gombert
authors.forename: D
authors.initials: D
authors.lastname: Sicard
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000150:complications / Q000188:drug therapy*; D019380:Anti-HIV Agents / Q000009:adverse effects* / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D019694:Hepatitis B, Chronic / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D012010:Red-Cell Aplasia, Pure / Q000139:chemically induced*; D018894:Reverse Transcriptase Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D015215:Zidovudine / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D019380:Anti-HIV Agents; D018894:Reverse Transcriptase Inhibitors; D015215:Zidovudine